Source comparison
Third-Party Verification vs Supplier-Issued Certificates
Certificates of Analysis from the manufacturing lab are industry standard. Third-party verification by an independent laboratory is not. Real Peptides sends every ARA-290 batch to an external ISO 17025-accredited lab for HPLC and mass spectrometry analysis bef
This comparison does not assign a generated winner or score.
- Certificates of Analysis from the manufacturing lab are industry standard. Third-party verification by an independent laboratory is not. Real Peptides sends every ARA-290 batch to an external ISO 17025-accredited lab for HPLC and mass spectrometry analysis before shipping. The independent lab receives blinded samples (no batch identifiers) and reports purity, molecular weight confirmation, and impurity profiling without knowing the expected results. Competitors relying solely on in-house testing eliminate this verification layer. If the synthesis run produces 96% purity instead of the advertised 99%, there's no external checkpoint to flag the variance.
- Mass spectrometry identifies molecular weight with ±1 Dalton precision, confirming that the synthesised peptide matches ARA-290's theoretical mass of 1,228.4 Da. HPLC measures purity but doesn't confirm identity. A peptide could show 99% purity by HPLC and still be the wrong sequence if synthesis started with incorrect amino acids. The combination of HPLC and MS is the quality standard for research-grade peptides; suppliers offering only HPLC data are providing incomplete verification. In our experience reviewing supplier data across 200+ peptide orders, fewer than 12% of competitors publish both HPLC chromatograms and mass spectra for each batch. Most provide a single purity percentage without supporting analytical data.
- Another gap: endotoxin testing. Bacterial endotoxins (lipopolysaccharides from E. coli cell walls) contaminate peptides synthesised in bacterial expression systems and can trigger inflammatory responses in cell culture and animal studies. Real Peptides tests every batch using the Limulus Amebocyte Lysate (LAL) assay, ensuring endotoxin levels below 1 EU/mg. Competitors using bacterial expression without endotoxin removal may ship peptides with 10–50 EU/mg. Levels that confound research outcomes in immune response studies. This isn't listed on standard Certificates of Analysis unless specifically requested.